2014
DOI: 10.3171/2014.6.peds13674
|View full text |Cite
|
Sign up to set email alerts
|

Aquaporin-4 autoimmunity masquerading as a brainstem tumor

Abstract: Brainstem glioma is a highly devastating disease, and any mass-like lesion in the brainstem can raise suspicion of this diagnosis. However, other inflammatory, demyelinating, or degenerative diseases can mimic brainstem glioma in clinical presentation and imaging features. Therefore, diagnosis based solely on imaging is often insufficient for brainstem lesions and may lead to incorrect diagnosis and treatment. This case report is the first description of central nervous system aquapori… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 22 publications
0
4
0
Order By: Relevance
“…In view of MRI, cord spinal T2 lesions non-suggestive of MS, and tests for anti-aquaporin 4(AQP4) antibodies in serum and CSF were weakly positive, we diagnosed her neuromyelitis optica spectrum disorder(NMOSD). Although brainstem syndromes and short myelitis lesions [22] were reported in NMOSD [23, 24], we looked for other possible disorders involving auto-immune encephalitis and found anti-NMDAR-Ab in CSF and serum before steroid was applied.…”
Section: Discussionmentioning
confidence: 99%
“…In view of MRI, cord spinal T2 lesions non-suggestive of MS, and tests for anti-aquaporin 4(AQP4) antibodies in serum and CSF were weakly positive, we diagnosed her neuromyelitis optica spectrum disorder(NMOSD). Although brainstem syndromes and short myelitis lesions [22] were reported in NMOSD [23, 24], we looked for other possible disorders involving auto-immune encephalitis and found anti-NMDAR-Ab in CSF and serum before steroid was applied.…”
Section: Discussionmentioning
confidence: 99%
“…At present, some studies suggest AQP4 may be a marker for the progression of malignant glioma [ 21 ], while others argue that AQP4 has no impact on the overall survival of IDH-wildtype GBMs [ 22 ]. As for immune-related aspects, there is little research regarding AQP4 and glioma’s immune system within the last ten years except for two case reports [ 23 , 24 ]. Its role in the glioma immune microenvironment is yet to be revealed.…”
Section: Introductionmentioning
confidence: 99%
“…37,38 The spectrum extended to enclose atypical presentations; tumor like lesions, progressive encephalopathy and hormonal disturbances like amenorrhea. 39,40 Thus, the diagnosis may be missed or delayed in patients presenting with atypical presentations or non-CNS manifestations at onset.…”
Section: Misdiagnosis Is Commonmentioning
confidence: 99%